METHOD FOR PREVENTION OF RECURRENT BLEEDING IN DUODENAL ULCERS Russian patent published in 2024 - IPC A61B17/00 A61B1/273 

FIELD: medicine.

SUBSTANCE: invention relates to abdominal surgery and gastroenterology, and can be used for prevention of recurrent bleeding in duodenal ulcers. Such indicators as the size of the ulcer, localization of the ulcer, J.A.Forrest type of bleeding, type of hemostasis, presence of a comorbid pathology, administration of anticoagulants or antiplatelet agents, presence of extravasation during transcatheter angioembolization or preventive embolisation. Derived values are assigned points, the points are summed up and the risk of recurrent bleeding is assessed according to the groups, and if the total score is 3–7, it corresponds to a low risk of recurrent bleeding, 8–11 points—an average risk of recurrent bleeding, 12–13 points—a high risk of recurrent bleeding. In the group of low risk of recurrent haemorrhage after combined endoscopic haemostasis, dynamic observation is carried out. In the group of average risk of recurrent bleeding, one-stage hybrid hemostasis is used—combined endoscopy combined with transcatheter angioembolization, followed by dynamic observation. In the group of high risk of recurrent bleeding, one-stage hybrid hemostasis is used—combined endoscopic surgery combined with transcatheter angioembolization, followed by 24-hour surgical treatment.

EFFECT: method enables optimizing the therapeutic approach in the patients with duodenal ulcers by assessing the risk of recurrent bleeding using hybrid hemostasis techniques and using a therapeutic algorithm.

3 cl, 1 dwg, 3 ex